• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users.一种聚乙二醇标记物在防止海洛因使用者尿液造假方面的必要性及效用
Drug Alcohol Depend. 2015 Aug 1;153:201-6. doi: 10.1016/j.drugalcdep.2015.05.021. Epub 2015 May 27.
2
Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution program.聚乙二醇标记系统在阿片类药物替代治疗项目尿液药物筛查中的效能
Eur Addict Res. 2008;14(4):186-9. doi: 10.1159/000141642. Epub 2008 Jun 27.
3
Distinguishing heroin abuse from codeine administration in the urine of Chinese people by UPLC-MS-MS.采用 UPLC-MS-MS 技术对中国人尿样中海洛因滥用与可待因用药进行区分。
J Anal Toxicol. 2013 Apr;37(3):166-74. doi: 10.1093/jat/bks093. Epub 2013 Jan 12.
4
Detection of acetylcodeine in urine as an indicator of illicit heroin use: method validation and results of a pilot study.尿液中乙酰可待因的检测作为非法使用海洛因的指标:方法验证及一项初步研究的结果
Clin Chem. 2001 Feb;47(2):301-7.
5
Using Papaverine and Its Metabolites, 6-Desmethyl Papaverine and 4',6-Didesmethyl Papaverine as Biomarkers to Improve the Detection Time of Heroin Use.利用罂粟碱及其代谢物 6-去甲基罂粟碱和 4',6-二去甲基罂粟碱作为生物标志物来延长海洛因使用的检测时间。
J Anal Toxicol. 2019 Sep 10;43(8):600-606. doi: 10.1093/jat/bkz069.
6
Bedside urine testing for fentanyl in self-reported heroin users in a tertiary Brisbane emergency department.在布里斯班一家三级急诊室中,对自述使用海洛因的患者进行床边尿液芬太尼检测。
Emerg Med Australas. 2024 Aug;36(4):648-649. doi: 10.1111/1742-6723.14446. Epub 2024 May 27.
7
Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.街头芬太尼使用:自我报告与尿液毒理学之间的经验、偏好和一致性。
Int J Drug Policy. 2019 Sep;71:3-9. doi: 10.1016/j.drugpo.2019.05.020. Epub 2019 May 27.
8
Validation of meconin as a marker for illicit opiate use.
J Anal Toxicol. 2007 Mar;31(2):105-8. doi: 10.1093/jat/31.2.105.
9
[Comparison of morphine and codeine concentration in urines of heroin abusers and codeine users].[海洛因滥用者和可待因使用者尿液中吗啡和可待因浓度的比较]
Fa Yi Xue Za Zhi. 2012 Dec;28(6):426-8.
10
Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine.受损驾驶员血液中吗啡与可待因的浓度比可作为使用海洛因而非服用可待因药物的证据。
Clin Chem. 2001 Nov;47(11):1980-4.

引用本文的文献

1
[Narcotic Use under Probation and Parole Supervision - A longitudinal Study of Risk-group-specific Recidivism under Abstinence Conditions].缓刑和假释监督下的麻醉品使用——禁欲条件下特定风险群体累犯的纵向研究
Gesundheitswesen. 2024 Feb;86(2):148-154. doi: 10.1055/a-2173-8063. Epub 2023 Dec 21.
2
Advances in testing for sample manipulation in clinical and forensic toxicology - Part A: urine samples.临床和法医毒理学中样品操作检测的进展 - 第 A 部分:尿液样本。
Anal Bioanal Chem. 2023 Sep;415(21):5101-5115. doi: 10.1007/s00216-023-04711-w. Epub 2023 May 5.
3
No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone.接受纳洛酮带回家治疗后,海洛因使用者中没有代偿性药物使用风险行为的证据。
Addict Behav. 2017 Aug;71:104-106. doi: 10.1016/j.addbeh.2017.03.008. Epub 2017 Mar 9.

本文引用的文献

1
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users.丁丙诺啡维持治疗的海洛因使用者中,鼻内丁丙诺啡与丁丙诺啡/纳洛酮的滥用可能性比较
Addict Biol. 2015 Jul;20(4):784-98. doi: 10.1111/adb.12163. Epub 2014 Jul 25.
2
Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection.非治疗寻求的海洛因使用者中的丙型肝炎感染:可卡因注射的负担。
Am J Addict. 2013 Nov-Dec;22(6):613-8. doi: 10.1111/j.1521-0391.2013.12058.x. Epub 2013 Jun 6.
3
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.阿片类药物、苯二氮䓬类药物和/或酒精联合使用的风险、管理和监测。
Postgrad Med. 2013 Jul;125(4):115-30. doi: 10.3810/pgm.2013.07.2684.
4
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.急性口服纳曲酮对可卡因滥用者口服 D-苯丙胺和吸食可卡因的主观和生理效应的影响。
Neuropsychopharmacology. 2013 Nov;38(12):2427-38. doi: 10.1038/npp.2013.143. Epub 2013 Jun 5.
5
Diversity in causes and characteristics of drug-induced deaths in an urban setting.城市环境中药物导致死亡的原因和特征的多样性。
Scand J Public Health. 2013 Mar;41(2):119-25. doi: 10.1177/1403494812472007. Epub 2013 Jan 9.
6
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.阿片类药物维持治疗作为纽约市阿片类药物依赖者的减少伤害工具:有必要扩大在边缘化人群中使用丁丙诺啡/纳洛酮的机会。
J Addict Dis. 2012;31(3):278-87. doi: 10.1080/10550887.2012.694603.
7
Polydrug abuse: a review of opioid and benzodiazepine combination use.多药滥用:阿片类药物和苯二氮䓬类药物联合使用综述。
Drug Alcohol Depend. 2012 Sep 1;125(1-2):8-18. doi: 10.1016/j.drugalcdep.2012.07.004. Epub 2012 Aug 2.
8
Urine drug testing: current recommendations and best practices.尿液药物检测:当前的建议和最佳实践。
Pain Physician. 2012 Jul;15(3 Suppl):ES119-33.
9
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
10
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.丁丙诺啡的转移和滥用:来自治疗患者和医生全国调查的结果。
Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.

一种聚乙二醇标记物在防止海洛因使用者尿液造假方面的必要性及效用

Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users.

作者信息

Jones Jermaine D, Atchison Jared J, Madera Gabriela, Metz Verena E, Comer Sandra D

机构信息

Division of Substance Abuse, New York State Psychiatric Institute/College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032, USA.

Translational Research Training Program in Addiction at City College of New York & Sophie Davis School of Biomedical Education, 160 Convent Avenue, New York, NY 10032, USA.

出版信息

Drug Alcohol Depend. 2015 Aug 1;153:201-6. doi: 10.1016/j.drugalcdep.2015.05.021. Epub 2015 May 27.

DOI:10.1016/j.drugalcdep.2015.05.021
PMID:26051158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4509811/
Abstract

BACKGROUND

Deceptive methods of falsifying urine samples are of concern for anyone who relies on accurate urine toxicology results. A novel method to combat these efforts utilizes polyethylene glycol (PEG) markers administered orally prior to providing a urine sample. By using various PEG combinations to create a tracer capsule of unique composition, each urine sample can be matched to that individual. The goal of this study was to determine the effectiveness of using the PEG marker system among active heroin users screening for research studies.

METHODS

Upon each screening visit, participants (N=55) were randomized to provide an unobserved urine sample, or the PEG tracer procedure was used. LCMS analysis was used to distinguish the PEG combinations, and allowed us to provide a unique qualitative analysis of patterns of drug use (N=168, total urine specimens).

RESULTS

The unique composition of the tracer capsules was accurately detected in 83.5% of the urine specimens. Analyses of inconsistencies implicated a number of possible attempts at fraudulence (11.4%) and investigator/lab error (5.1%). Among this sample, the concurrent use of multiple classes of psychoactive drugs was more common than not, though concomitant drug use was often underreported.

CONCLUSION

Urine drug testing should be the minimum standard for obtaining information about drug use as self-report was unreliable even in a situation where there were no perceived adverse consequences for full disclosure. In cases where there are significant pressures for individuals to falsify these data, more protective collection methods such as the PEG marker system should be considered.

摘要

背景

对于任何依赖准确尿液毒理学检测结果的人来说,伪造尿液样本的欺骗方法都令人担忧。一种对抗这些行为的新方法是在提供尿液样本之前口服聚乙二醇(PEG)标记物。通过使用各种PEG组合来创建具有独特成分的示踪胶囊,每个尿液样本都可以与个体进行匹配。本研究的目的是确定在为研究筛选的活跃海洛因使用者中使用PEG标记系统的有效性。

方法

在每次筛查就诊时,参与者(N = 55)被随机分配提供一份无人监督的尿液样本,或采用PEG示踪程序。使用液相色谱 - 质谱联用(LCMS)分析来区分PEG组合,并使我们能够对药物使用模式进行独特的定性分析(N = 168,尿液样本总数)。

结果

在83.5%的尿液样本中准确检测到了示踪胶囊的独特成分。对不一致情况的分析表明存在一些可能的欺诈企图(11.4%)和调查人员/实验室错误(5.1%)。在这个样本中,同时使用多种精神活性药物的情况较为常见,尽管药物的同时使用情况往往报告不足。

结论

尿液药物检测应作为获取药物使用信息的最低标准,因为即使在完全披露没有可察觉的不良后果的情况下,自我报告也不可靠。在个人有很大压力伪造这些数据的情况下,应考虑采用更具保护性的采集方法,如PEG标记系统。